Active Ingredient	Naloxone
Manufacturer	Kharkiv Pharmaceutical
Origin	Ukraine
Reference	N/A

What is Naloxone-ZN solution (Naloxone) used for?

Naloxone is used in cases of emergency when an opioid overdose has occurred. Injected into the muscle, into the vein or under the skin, it works as an opiate antagonist and can block and reverse the effects of an opioid overdose.

How should I use Naloxone-ZN solution (Naloxone)?

Naloxone is liquid medication for injection. It should be injected intramuscularly (into a muscle), intravenously (into a vein) or subcutaneously (under the skin). Read the instructions thoroughly so you know how to perform the injection if needed.

Make sure to call for medical help after giving Naloxone and tell the attending professional that naloxone has been administered.

Only use Naloxone in cases of emergency.

Continue to watch for signs of overdose after the first injection. If the person does not respond, repeated injections may be necessary.

What are the side effects of Naloxone-ZN solution (Naloxone)?

Naloxone reverses the effects of opioids. As a result it will result in side effects very similar to opioid withdrawal. Side effects the patient may show include:

• nausea
• vomiting
• diarrhea
• stomach pain
• fever
• sweating
• body aches
• weakness
• tremors
• fast heart rate
• pounding heartbeats
• increased blood pressure
• feeling nervous, restless, or irritable
• goosebumps
• shivering
• runny nose
• yawning
• seizures
• crying
• stiffness
• overactive reflexes

The patient may also experience tachycardia, hypotension, hypertension, dizziness and headaches as a result of Naloxone.

Please Note

Naloxone slows reaction times and decreases alertness. Activities needing concentration and alertness should not be performed.

If you are taking any narcotic pain killers, the effect of these will be reduced by Naloxone.

The safety of Naloxone in pregnant and breastfeeding women has not been thoroughly established.

People with heart disease must be watched carefully if given Naloxone.